Pulmonary Hypertension

Widening the Definition and Use of Palliative Care in PAH    Pulmonology Advisor While the prognosis for patients with pulmonary arterial hypertension (PAH) has improved since the introduction of PAH-specific therapies, mortality and ...

ANCA Autoantibodies Linked to Worse Scleroderma Prognosis, Study Finds    Scleroderma News A large study has shown that having ANCA autoantibodies is associated with worse prognosis in scleroderma patients.

mild pulmonary hypertension Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News Posted: 02 Jan 2019 12:00 AM PST Throughout the past year , Pulmonary Hypertension News has brought you information about important discoveries, treatment developments, clinical trials, and other events dealing with pulmonary hypertension (PH). As we look ahead to 2019, here are the 10 most-read stories of 2018, with a summary of their significance to PH patients, family members, and caregivers. No. 10 — "Six-minute Walk Test Still Key in Predicting Long-Term PAH Outcomes, Study Confirms" The six-minute walk test (6MWT), the goal of which is to walk as far as possible in six minutes, is commonly used to evaluate exercise tolerance in patients with chronic respiratory disease and heart failure. Analysis of clinical data collected during the Phase 3 SERAPHIN trial ( NCT00660179 ) in patients wi...

pulmonary hypertension medications SAPH Patients May Benefit from PH-specific Therapy, Study Suggests - Pulmonary Hypertension News Posted: 29 Mar 2019 01:30 AM PDT Patients with sarcoidosis -associated pulmonary hypertension (SAPH) can improve their levels of a key biomarker after receiving specific treatment for PH, which suggests that PH-specific treatment may benefit this patient population, according to a real-world study. The study, " Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension ," was published in the journal Nature Scientific Reports . Although reports have shown a high frequency of PH in people with sarcoidosis , no specific PH therapies are available for these patients. Thorough understanding how PH affects blood flow and heart function in people with SAPH is limited, particularly in real-world practice. Therefore, a team at Duke Univers...

idiopathic pulmonary hypertension Idiopathic Pulmonary Fibrosis Treatment Market Strategies and Forecasts Includes Major Key Players - TechZiffy Posted: 27 Mar 2019 06:59 AM PDT Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease distinguished by progressive and irreversible reduction in lung function characterized by thickening and damaging of the walls of the air sacs (called alveoli). Common symptoms include, dry cough, gradual onset of shortness of breath, nail clubbing, and fatigue. Other symptoms are weight loss and muscle and joint pain. Further complications include, hypertension, heart failure, pulmonary embolism or pneumonia. Major factors causing damage to the lungs include, acid reflux from stomach, certain viruses such as Epstein Barr virus and herpes virus or environmental factors such as breathing in dust such as silica dust, asbestos fibers, hard metal dust, and coal dust. Treatments for idiopathic pulmonary fibrosi...

Pulmonary Hypertension Particular Histological Pattern Linked to Severe Pulmonary Hypertension in COPD - Pulmonology Advisor Widening the Definition and Use of Palliative Care in PAH - Pulmonology Advisor Hearing 'It Could Be Worse' Makes Me Feel Invalidated - Pulmonary Hypertension News Transition from PDE5i to Adempas Without Washout is Viable for PH - Pulmonary Hypertension News Particular Histological Pattern Linked to Severe Pulmonary Hypertension in COPD - Pulmonology Advisor Posted: 29 Mar 2019 01:00 AM PDT Compared with individuals with chronic obstructive pulmonary disease (COPD) with moderate pulmonary hypertension (PH) or without PH, those with acute PH-COPD have lower capillary density and significantly greater pulmonary microvessel muscularization, according to a study recently published in CHEST. This study included 30 participants with COPD who underwent lung transplant, 10 of w...

ANCA Autoantibodies Linked to Worse Scleroderma Prognosis, Study Finds    Scleroderma News A large study has shown that having ANCA autoantibodies is associated with worse prognosis in scleroderma patients.